publication . Article . 2003

Pancreatitis Associated With Atypical Antipsychotics: From the Food and Drug Administration's MedWatch Surveillance System and Published Reports

Elizabeth A. Koller; James T. Cross; P. Murali Doraiswamy; Saul N. Malozowski;
Open Access
  • Published: 01 Sep 2003
Study Objective. To investigate the relative numbers and clinical characteristics of pancreatitis in patients treated with the atypical antipsychotic agents, clozapine, olanzapine, and risperidone, versus the conventional neuroleptic, haloperidol. Design. Pharmacovigilance study of pooled, spontaneously reported adverse events. Setting. Government-affiliated drug evaluation center. Patients. One hundred ninety-two patients who developed pancreatitis during treatment with one or more antipsychotic agents. Intervention. Patients were identified with the Food and Drug Administration's MedWatch surveillance program and a MEDLINE search. Measurements and Main Results...
free text keywords: Risperidone, medicine.drug, medicine, Adverse effect, Pharmacology, Pancreatitis, medicine.disease, Olanzapine, Atypical antipsychotic, medicine.drug_class, Anesthesia, Internal medicine, medicine.medical_specialty, Clozapine, business.industry, business, Haloperidol, Antipsychotic, medicine.medical_treatment
Powered by OpenAIRE Research Graph
Any information missing or wrong?Report an Issue